Cingulate Therapeutics

Cingulate Therapeutics

Verified
Disruptive Technology Changing the Paradigm of Oral Drug Delivery.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$30—45m (Dealroom.co estimates Jul 2018.)
Morristown New Jersey (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
*
N/A

$25.0m

IPO
Total Funding000k

Recent News about Cingulate Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.